Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Thursday the launch of a new, advanced ultrasound system designed to improve clinician efficiency.The SiteRite 9 Ultrasound System, an all-in-one system, delivers enhanced image quality and vessel assessment tools to aid in first attempt IV insertion success.It helps to improve clinician efficiency when placing peripherally inserted central catheters or PICCs, central venous catheters, IV lines and other vascular access devices.The system is designed with a user-friendly experience on an updated 15.6-inch touch screen with enhanced image quality.

医疗技术公司Becton，Dickinson and Co.或BD（BDX）周四宣布推出一款旨在提高临床医生效率的新型先进超声系统。SiteRite 9超声系统是一个一体化系统，可提供增强的图像质量和血管评估工具，以帮助首次尝试IV插入成功。当放置外周插入的中心导管或PICC，中心静脉导管，IV线和其他血管通路装置时，它有助于提高临床医生的效率。该系统在更新的15.6英寸触摸屏上具有用户友好的体验，可提高图像质量。

It provides catheter placement tools and technologies to support clinicians during the vascular access device insertion process..

它提供导管放置工具和技术，以在血管通路装置插入过程中支持临床医生。。

The system includes integrated visualization tools such as the Cue Needle Tracking System to provide nurses with continuous and real-time needle tracking. Further, the Sherlock 3CG+ Tip Confirmation System ensures proper catheter tip navigation and location.SiteRite 9 also features smart, connected technology such as vessel assessment tools.

该系统包括集成的可视化工具，如提示针跟踪系统，为护士提供连续和实时的针跟踪。此外，Sherlock 3CG+尖端确认系统可确保正确的导管尖端导航和定位。SiteRite 9还具有智能连接技术，如船舶评估工具。

It automatically detects the vessel, then pair with vessel measurement tools to help clinicians select the appropriate catheter.Additional system capabilities include patient data look up with information capture, auto-filling capabilities and records transfer to help support clinician workflow. For comments and feedback contact: editorial@rttnews.comBusiness News.

它自动检测血管，然后与血管测量工具配对，以帮助临床医生选择合适的导管。其他系统功能包括患者数据查找以及信息采集，自动填充功能和记录传输，以帮助支持临床医生的工作流程。有关意见和反馈，请联系：editorial@rttnews.combusiness新闻。

Biotech Stocks Facing FDA Decision In November 2023

2023年11月FDA决定面临的生物技术股票

Biotech Stocks Facing FDA Decision In October 2023

2023年10月FDA决定面临的生物技术股票

Biotech Stocks Facing FDA Decision in August 2023

2023年8月FDA决定面临的生物技术股票